FR2521992B1 - Nouveaux composes de pyridine utiles comme medicaments - Google Patents

Nouveaux composes de pyridine utiles comme medicaments

Info

Publication number
FR2521992B1
FR2521992B1 FR838303036A FR8303036A FR2521992B1 FR 2521992 B1 FR2521992 B1 FR 2521992B1 FR 838303036 A FR838303036 A FR 838303036A FR 8303036 A FR8303036 A FR 8303036A FR 2521992 B1 FR2521992 B1 FR 2521992B1
Authority
FR
France
Prior art keywords
medicaments
compounds useful
pyridine compounds
novel pyridine
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR838303036A
Other languages
English (en)
Other versions
FR2521992A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maruko Pharmaceutical Co Ltd
Original Assignee
Maruko Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maruko Pharmaceutical Co Ltd filed Critical Maruko Pharmaceutical Co Ltd
Publication of FR2521992A1 publication Critical patent/FR2521992A1/fr
Application granted granted Critical
Publication of FR2521992B1 publication Critical patent/FR2521992B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
FR838303036A 1982-02-24 1983-02-24 Nouveaux composes de pyridine utiles comme medicaments Expired FR2521992B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57028392A JPS58146566A (ja) 1982-02-24 1982-02-24 ピリジン誘導体

Publications (2)

Publication Number Publication Date
FR2521992A1 FR2521992A1 (fr) 1983-08-26
FR2521992B1 true FR2521992B1 (fr) 1985-07-26

Family

ID=12247381

Family Applications (1)

Application Number Title Priority Date Filing Date
FR838303036A Expired FR2521992B1 (fr) 1982-02-24 1983-02-24 Nouveaux composes de pyridine utiles comme medicaments

Country Status (13)

Country Link
US (1) US4496735A (fr)
JP (1) JPS58146566A (fr)
KR (1) KR840003615A (fr)
AU (1) AU1146683A (fr)
BE (1) BE895994A (fr)
DE (1) DE3306146A1 (fr)
ES (1) ES8407476A1 (fr)
FR (1) FR2521992B1 (fr)
GB (1) GB2117760B (fr)
HU (1) HU188257B (fr)
IT (1) IT1168770B (fr)
NL (1) NL8300638A (fr)
SE (1) SE8301004L (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487933A (en) * 1981-12-14 1984-12-11 The Dow Chemical Company Titanium catalyzed transesterification
EP0242070A3 (fr) * 1986-04-17 1988-12-28 Imperial Chemical Industries Plc Dérivés d'esters d'acide phénylacrylique, procédé pour leur préparation et leur utilisation comme fongicides
DE3823991A1 (de) * 1988-07-15 1990-02-15 Basf Ag Heterocyclisch substituierte (alpha)-aryl-acrylsaeureester und fungizide, die diese verbindungen enthalten
US5194438A (en) * 1988-07-15 1993-03-16 Basf Aktiengesellschaft α-arylacrylates substituted by a trifluoromethylpyrimidinyloxy radical, fungicidal compositions and methods
CN1034934C (zh) * 1990-06-19 1997-05-21 明治制果株式会社 血管紧张素ii拮抗性吡啶衍生物的制备方法
US6878700B1 (en) 1998-12-29 2005-04-12 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
US6110922A (en) 1998-12-29 2000-08-29 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
US6867203B2 (en) * 1998-12-29 2005-03-15 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
US6521619B2 (en) 2000-06-29 2003-02-18 Icos Corporation Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agents
NZ523445A (en) 2000-06-29 2004-10-29 Abbott Lab Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
WO2015027067A2 (fr) * 2013-08-23 2015-02-26 Virginia Commonwealth University Dérivés de type nitrates d'ester d'aldéhydes aromatiques doués de multiples propriétés pharmacologiques pour traiter la drépanocytose

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54144375A (en) * 1978-04-27 1979-11-10 Ishihara Sangyo Kaisha Ltd 4-(5-trifluoromethyl-2-pyridyloxy)phenoxyalkane derivative and herbicide containing the same
CA1134828A (fr) * 1978-12-28 1982-11-02 Tadao Tanouchi Derives de la pyridine
BR8005226A (pt) * 1979-08-23 1981-03-04 Du Pont Composto herbicida, composicao e processo para o controle de vegetacao indesejavel, composicao e processo para o controle de er vas gramineas em plantas de folhas grandes e processo para preparar um composto herbicida

Also Published As

Publication number Publication date
GB2117760B (en) 1985-12-11
DE3306146A1 (de) 1983-09-01
IT1168770B (it) 1987-05-20
GB2117760A (en) 1983-10-19
ES519961A0 (es) 1984-10-01
NL8300638A (nl) 1983-09-16
IT8347765A1 (it) 1984-08-23
US4496735A (en) 1985-01-29
SE8301004L (sv) 1983-08-25
JPS58146566A (ja) 1983-09-01
KR840003615A (ko) 1984-09-15
BE895994A (fr) 1983-06-16
FR2521992A1 (fr) 1983-08-26
SE8301004D0 (sv) 1983-02-23
HU188257B (en) 1986-03-28
GB8304604D0 (en) 1983-03-23
AU1146683A (en) 1983-09-01
ES8407476A1 (es) 1984-10-01
IT8347765A0 (it) 1983-02-23

Similar Documents

Publication Publication Date Title
BE882305A (fr) Nouveaux composes de benzodiazepine
FR2530626B1 (fr) Composes de carbostyryle
FR2528049B1 (fr) Nouveaux composes organo-magnesiens
FI831714L (fi) Maetanordning foer maetning av ett materialark
FI833117A7 (fi) Dihydropyridiner
DE3366850D1 (de) Prilling
FI833860L (fi) Skyddsskikt foer hjaessdelen av ett strukturellt tredimensionellt daeck
DK237283A (da) Fungicidt praeparat
FR2521992B1 (fr) Nouveaux composes de pyridine utiles comme medicaments
FI830247A0 (fi) Trisubstituerade urea- och tioureafoereningar laempliga mot aoderfoerkalkning, kompositioner innehaollande dessa och foerfarande foer deras framstaellning
FR2536398B1 (fr) Nouveaux composes heterocycliques
FI821851A7 (fi) Anordning foer foerdelning av sidobraedorna i ett saogverk
FI830216A0 (fi) Foerfarande foer framstaellning av ett mineralrostgods
FI830242A0 (fi) Anordning foer murning av ett metallurgiskt kaerl, saerskilt en staolkonverter
DK147284D0 (da) Granulaert herbicidt praeparat
JPS5687567A (en) Manufacture of molecular compound
FR2505337B1 (fr) Nouveaux thienyl- et benzothienyl-tert-butylaminophenoxypropanols utiles comme medicaments b-bloquants selectifs
DK66684D0 (da) Boelgelaengdemultiplekser henholdsvis boelgelaengdedemultiplekser
ES520799A0 (es) Derivados de acido pentanodioico.
FI823464A0 (fi) Fastsaettning av ett tudelat kraftoeverfoeringshjul
FI833951A0 (fi) Foerfarande foer framstaellning av ett vaermeisolerat ledningsroer
FI834399A0 (fi) Foerfarande foer utvinning av metaller fraon en uppslamning innehaollande dessa i loest form
FI833105L (fi) Anordning foer maetning av nedhaengningen av en ledare i ett vulkaniseringsroer
BR8304136A (pt) Preparacao 2-t-butil-5-cloropirimidina
FI821825A0 (fi) Foerfarande foer framstaellning av ett tetracyklinderivat

Legal Events

Date Code Title Description
ST Notification of lapse